Ebiga-VISION GmbH

Pharmaceutical Companies · Vorpommern-Greifswald

Ebiga-VISION GmbH is a pharmaceutical company based in Vorpommern-Greifswald, Mecklenburg-Vorpommern, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Ebiga-VISION GmbH – Address & Contact

Address

Brandteichstr. 20
17489 Vorpommern-Greifswald

Ebiga-VISION GmbH Overview

Ebiga-VISION GmbH is a pharmaceutical company based in Vorpommern-Greifswald, Mecklenburg-Vorpommern. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Ebiga-VISION GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

Location & Contact

Ebiga-VISION GmbH can be reached at the following address: Brandteichstr. 20, 17489 Vorpommern-Greifswald – Phone: 030577072280. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Mecklenburg-Vorpommern or all Pharmaunternehmen in Germany on Sanoliste.

Pharmazeutische Regulierung in Deutschland

Pharmaceutical companies such as Ebiga-VISION GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.

Arzneimittelversorgung & Marktumfeld

With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Ebiga-VISION GmbH, based in Vorpommern-Greifswald, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.

Pharmastandort Mecklenburg-Vorpommern

Mecklenburg-Vorpommern is a significant pharmaceutical location in Germany. Companies such as Ebiga-VISION GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.

Frequently asked questions about Ebiga-VISION GmbH

What does Ebiga-VISION GmbH do?

Ebiga-VISION GmbH is im Bereich the Augenheilkande tätig. Sie erforscht, develops and disributes Konzepte zur Prävention and zum Umgang at chronischen Augenerkrankungen. Ihre Schwerpunkte liegen on the altersbedingten Makuladegeneration, on the Glaskörperdegeneration and on Diabetes with den Folgen for the Sehkraft.

What medicines does Ebiga-VISION GmbH manufacture?

Ebiga-VISION GmbH is a pharmaceutical company in Vorpommern-Greifswald. Einführung in the Ebiga-VISION GmbH Ebiga-VISION GmbH is ein in Germany ansässiges company, the sich on the Lieferung of hochwertigen optischen Systemen and Geräten spe Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.

How are medicines approved in Germany?

Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.

What does GMP mean in pharmaceutical production?

GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.

Ebiga-VISION GmbH on social media

Pharmaceutical Companies in Mecklenburg-Vorpommern

All Pharmaceutical Companies in Mecklenburg-Vorpommern on Sanoliste — or discover all categories by federal state.

Last updated: 17.03.2026 · Category: Pharmaceutical Companies